Anastasia Levitin

Dr. Anastasia Levitin

Henry E. Riggs School of Applied Life Sciences, Keck Graduate Institute, 535 Watson Drive, Claremont, CA 91711, USA
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2007 in Eukaryotic Cell
Verified
Journal Article
Open access
MMMikhail Martchenko
Mikhail Martchenko
Anastasia LevitinAnastasia Levitin
Anastasia Levitin
MWMalcolm Whiteway
Malcolm Whiteway
Many putative transcription factors in the pathogenic fungus Candida albicans contain sequence similarity to well-defined transcriptional regulators in the budding yeast Saccharomyces cerevisiae , but this sequence similarity is often limited to the DNA binding domains of the molecules. The Gcn4p and Gal4p proteins of Saccharomyces cerevisiae are highly studied and well-understood eukaryotic transcription factors of the basic leucine zipper (Gcn4p) and C 6 zinc cluster (Gal4p) families; C. albicans has C. albicans Gcn4p (CaGcn4p) and CaGal4p with DNA binding domains highly similar to their S. cerevisiae counterparts. Deletion analysis of the CaGcn4p protein shows that the N′ terminus is needed for transcriptional activation; an 81-amino-acid region is critical for this function, and this domain can be coupled to a lexA DNA binding module to provide transcription-activating function in a heterologous reporter system. Deletion analysis of the C. albicans Gal4p identifies a C-terminal 73-amino-acid-long transcription-activating domain that also can be transferred to a heterologous reporter construct to direct transcriptional activation. These two transcriptional activation regions show no sequence similarity to the respective domains in their S. cerevisiae homologs, and the two C. albicans transcription-activating domains themselves show little similarity.

18 August 2020 in ACS Omega
Verified
Journal Article
Closed access
MAMasami Amakawa
Masami Amakawa
SGSoneli Gunawardana
Soneli Gunawardana
AJAlexy Jabbour
Alexy Jabbour
AHAlan Hernandez
Alan Hernandez
CPChase Pasos
Chase Pasos
Anastasia LevitinAnastasia Levitin
Anastasia Levitin

31 August 2020 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
SASaleem Alameh
Saleem Alameh
GBGloria Bartolo
Gloria Bartolo
SOSummer O’bRien
Summer O’bRien
EHElizabeth A. Henderson
Elizabeth A. Henderson
LGLeandra O. Gonzalez
Leandra O. Gonzalez
Mikhail Martchenko ShilmanMikhail Martchenko Shilman
Mikhail Martchenko Shilman
Anthrax is a major zoonotic disease of wildlife, and in places like West Africa, it can be caused by Bacillus anthracis in arid nonsylvatic savannahs, and by B. cereus biovar anthracis (Bcbva) in sylvatic rainforests. Bcbva-caused anthrax has been implicated in as much as 38% of mortality in rainforest ecosystems, where insects can enhance the transmission of anthrax-causing bacteria. While anthrax is well-characterized in mammals, its transmission by insects points to an unidentified anthrax-resistance mechanism in its vectors. In mammals, a secreted anthrax toxin component, 83 kDa Protective Antigen (PA83), binds to cell-surface receptors and is cleaved by furin into an evolutionary-conserved PA20 and a pore-forming PA63 subunits. We show that PA20 increases the resistance of Drosophila flies and Culex mosquitoes to bacterial challenges, without directly affecting the bacterial growth. We further show that the PA83 loop known to be cleaved by furin to release PA20 from PA63 is, in part, responsible for the PA20-mediated protection. We found that PA20 binds directly to the Toll activating peptidoglycan-recognition protein-SA (PGRP-SA) and that the Toll/NF-κB pathway is necessary for the PA20-mediated protection of infected flies. This effect of PA20 on innate immunity may also exist in mammals: we show that PA20 binds to human PGRP-SA ortholog. Moreover, the constitutive activity of Imd/NF-κB pathway in MAPKK Dsor1 mutant flies is sufficient to confer the protection from bacterial infections in a manner that is independent of PA20 treatment. Lastly, Clostridium septicum alpha toxin protects flies from anthrax-causing bacteria, showing that other pathogens may help insects resist anthrax. The mechanism of anthrax resistance in insects has direct implications on insect-mediated anthrax transmission for wildlife management, and with potential for applications, such as reducing the sensitivity of pollinating insects to bacterial pathogens. Gram-positive Bacillus anthracis and B. cereus biovar anthracis cause anthrax in mammals by secreting anthrax toxin. Recent studies report the devastating ecological effects anthrax has on the wildlife in areas like tropical rainforests, where in the past 26 years, anthrax had been implicated in 38% of wildlife mortality, and where insects can act as the vectors for anthrax transmission. The anthrax-resistance mechanism in its insect vectors has not been identified. We discovered that one of anthrax toxin components reduces the sensitivity of insects to anthrax-causing bacilli and other bacteria, and that insect immunity Toll/NF-κB and Imd/NF-κB pathways play a role in this toxin-mediated protection. The toxin-mediated protection of insects would benefit the anthrax-causing bacteria by extending the lifespan of vectors and enhancing the pathogen transmission. Anthrax toxin component activation of NF-κB has also been found to exists in humans. Moreover, the activation of the innate NF-κB-dependent immunity by this anthrax toxin component has potential implications in protecting pollinating insects from bacterial pathogens.

4 July 2021 in ACS Infectious Diseases
Verified
Journal Article
Open access
Mikhail Martchenko ShilmanMikhail Martchenko Shilman
Mikhail Martchenko Shilman
GBGloria Bartolo
Gloria Bartolo
SASaleem Alameh
Saleem Alameh
JPJohnny W. Peterson
Johnny W. Peterson
WLWilliam S. Lawrence
William S. Lawrence
JWJoel West
Joel West
Anthrax is caused by Bacillus anthracis and can result in nearly 100% mortality due in part to anthrax toxin. Antimalarial amodiaquine (AQ) acts as a host-oriented inhibitor of anthrax toxin endocytosis. Here, we determined the pharmacokinetics and safety of AQ in mice, rabbits, and humans as well as the efficacy in the fly, mouse, and rabbit models of anthrax infection. In the therapeutic-intervention studies, AQ nearly doubled the survival of mice infected subcutaneously with a B. anthracis dose lethal to 60% of the animals (LD60). In rabbits challenged with 200 LD50 of aerosolized B. anthracis, AQ as a monotherapy delayed death, doubled the survival rate of infected animals that received a suboptimal amount of antibacterial levofloxacin, and reduced bacteremia and toxemia in tissues. Surprisingly, the anthrax efficacy of AQ relies on an additional host macrophage-directed antibacterial mechanism, which was validated in the toxin-independent Drosophila model of Bacillus infection. Lastly, a systematic literature review of the safety and pharmacokinetics of AQ in humans from over 2 000 published articles revealed that AQ is likely safe when taken as prescribed, and its pharmacokinetics predicts anthrax efficacy in humans. Our results support the future examination of AQ as adjunctive therapy for the prophylactic anthrax treatment.

8 September 2020 in ACS Omega
Verified
Journal Article
Closed access
TKTiffany H. Khaw
Tiffany H. Khaw
SWS. N. Michael Wong
S. N. Michael Wong
GHGenevieve Herle
Genevieve Herle
JDJean Patrick Gonzalez Dahua
Jean Patrick Gonzalez Dahua
ALAdhitya Logan
Adhitya Logan
Anastasia LevitinAnastasia Levitin
Anastasia Levitin

5 January 2021 in Insects
Verified
Journal Article
Open access
PDF file
GBGloria Bartolo
Gloria Bartolo
LGLeandra O. Gonzalez
Leandra O. Gonzalez
Anastasia LevitinAnastasia Levitin
Anastasia Levitin
Mikhail Martchenko ShilmanMikhail Martchenko Shilman
Mikhail Martchenko Shilman
The genders of Drosophila melanogaster vary in their sensitivities to microbial pathogens. While many of the immunity-related genes are located on the X chromosome, the polymorphisms within the Y chromosome were also shown to affect the immunity of flies. In this study, we investigated the necessity of individual genes on the Y chromosome (Y-genes) for male sensitivity to microbes. We identified several Y-genes whose genetic inactivation either increases or decreases the sensitivity of males to gastrointestinal infections with fungal Saccharomyces cerevisiae and bacterial Serratia liquefaciens. Specifically, the loss of function mutations in fly kl-5 and Ppr-Y Y-genes lead to increased and decreased sensitivity of males to fungal challenge, respectively, compared to female sensitivity. In contrast, mutations in Drosophila Pp1-Y1, kl-5, kl-3, Ppr-Y, CCY, and FDY Y-genes lead to increased sensitivity of males to bacterial infection, compared to females. Moreover, while these Y-genes are necessary, the Y chromosome is not sufficient for the sensitivity of males to microbes, since the sensitivity of XXY females to fungal and bacterial challenges was not different from the sensitivity of wild-type female flies, compared to males. This study assigns a new immunity-related function to numerous Y-genes in D.melanogaster.